171 related articles for article (PubMed ID: 15819814)
1. Severe azathioprine-induced myelotoxicity in a kidney transplant patient with thiopurine S-methyltransferase-deficient genotype (TPMT*3A/*3C).
Kurzawski M; Dziewanowski K; Ciechanowski K; Droździk M
Transpl Int; 2005 May; 18(5):623-5. PubMed ID: 15819814
[No Abstract] [Full Text] [Related]
2. TPMT genotype and its clinical implication in renal transplant recipients with azathioprine treatment.
Song DK; Zhao J; Zhang LR
J Clin Pharm Ther; 2006 Dec; 31(6):627-35. PubMed ID: 17176368
[TBL] [Abstract][Full Text] [Related]
3. Azathioprine-induced fatal myelosuppression in a renal-transplant recipient who carried heterozygous TPMT*1/*3C.
Tassaneeyakul W; Srimarthpirom S; Reungjui S; Chansung K; Romphruk A; Tassaneeyakul W
Transplantation; 2003 Jul; 76(1):265-6. PubMed ID: 12865824
[No Abstract] [Full Text] [Related]
4. The impact of thiopurine s-methyltransferase polymorphism on azathioprine-induced myelotoxicity in renal transplant recipients.
Kurzawski M; Dziewanowski K; Gawrońska-Szklarz B; Domański L; Droździk M
Ther Drug Monit; 2005 Aug; 27(4):435-41. PubMed ID: 16044099
[TBL] [Abstract][Full Text] [Related]
5. Thiopurine S-methyltransferase polymorphism in Iranian kidney transplant recipients.
Aghdaie MH; Azarpira N; Geramizadeh B; Sagheb M; Darai M; Rahsaz M; Malekhoseini SA
Exp Clin Transplant; 2011 Aug; 9(4):241-6. PubMed ID: 21819368
[TBL] [Abstract][Full Text] [Related]
6. The impact of thiopurine S-methyltransferase polymorphisms on azathioprine dose 1 year after renal transplantation.
Fabre MA; Jones DC; Bunce M; Morris PJ; Friend PJ; Welsh KI; Marshall SE
Transpl Int; 2004 Oct; 17(9):531-9. PubMed ID: 15349717
[TBL] [Abstract][Full Text] [Related]
7. [Association between metabolic enzyme genotype of azathioprine and drug tolerance in patients with rheumatic diseases].
Zhan ZP; Liang LQ; Yang XY; Wang YX; Huang M; Li H
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(25):1734-7. PubMed ID: 17919375
[TBL] [Abstract][Full Text] [Related]
8. Azathioprine-induced fatal myelosuppression in systemic lupus erythematosus patient carrying TPMT*3C polymorphism.
Boonsrirat U; Angsuthum S; Vannaprasaht S; Kongpunvijit J; Hirankarn N; Tassaneeyakul W; Avihingsanon Y
Lupus; 2008 Feb; 17(2):132-4. PubMed ID: 18250137
[TBL] [Abstract][Full Text] [Related]
9. Fatal myelotoxicity after azathioprine treatment.
Slanar O; Chalupná P; Novotný A; Bortlík M; Krska Z; Lukás M
Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):661-5. PubMed ID: 18600523
[TBL] [Abstract][Full Text] [Related]
10. Azathioprine and diffuse alveolar haemorrhage: the pharmacogenetics of thiopurine methyltransferase.
Perri D; Cole DE; Friedman O; Piliotis E; Mintz S; Adhikari NK
Eur Respir J; 2007 Nov; 30(5):1014-7. PubMed ID: 17978158
[TBL] [Abstract][Full Text] [Related]
11. Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease.
Cao Q; Zhu Q; Shang Y; Gao M; Si J
Digestion; 2009; 79(1):58-63. PubMed ID: 19252404
[TBL] [Abstract][Full Text] [Related]
12. Azathioprine-associated acute myeloid leukemia in a patient with Crohn's disease and thiopurine S-methyltransferase deficiency.
Yenson PR; Forrest D; Schmiegelow K; Dalal BI
Am J Hematol; 2008 Jan; 83(1):80-3. PubMed ID: 17696202
[TBL] [Abstract][Full Text] [Related]
13. Impact of the heterozygous TPMT*1/*3C genotype on azathioprine-induced myelosuppression in kidney transplant recipients in Thailand.
Vannaprasaht S; Angsuthum S; Avihingsanon Y; Sirivongs D; Pongskul C; Makarawate P; Praditpornsilpa K; Tassaneeyakul W; Tassaneeyakul W
Clin Ther; 2009 Jul; 31(7):1524-33. PubMed ID: 19695401
[TBL] [Abstract][Full Text] [Related]
14. Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease.
Gearry RB; Barclay ML
J Gastroenterol Hepatol; 2005 Aug; 20(8):1149-57. PubMed ID: 16048561
[TBL] [Abstract][Full Text] [Related]
15. The frequency and significance of thiopurine S-methyltransferase gene polymorphisms in azathioprine-treated renal transplant recipients.
Moloney FJ; Dicker P; Conlon PJ; Shields DC; Murphy GM
Br J Dermatol; 2006 Jun; 154(6):1199-200. PubMed ID: 16704656
[No Abstract] [Full Text] [Related]
16. Azathioprine-induced pancytopenia in homozygous thiopurine methyltransferase-deficient renal transplant recipients: a family study.
Escousse A; Mousson C; Santona L; Zanetta G; Mounier J; Tanter Y; Duperray F; Rifle G; Chevet D
Transplant Proc; 1995 Apr; 27(2):1739-42. PubMed ID: 7725481
[No Abstract] [Full Text] [Related]
17. Thiopurine S-methyltransferase genotype predicts azathioprine-induced myelotoxicity in kidney transplant recipients.
Formea CM; Myers-Huentelman H; Wu R; Crabtree J; Fujita S; Hemming A; Reed A; Howard R; Karlix JL
Am J Transplant; 2004 Nov; 4(11):1810-7. PubMed ID: 15476481
[TBL] [Abstract][Full Text] [Related]
18. Thiopurine methyltransferase: should it be measured before commencing thiopurine drug therapy?
Sanderson J; Ansari A; Marinaki T; Duley J
Ann Clin Biochem; 2004 Jul; 41(Pt 4):294-302. PubMed ID: 15298741
[TBL] [Abstract][Full Text] [Related]
19. Two cases of thiopurine methyltransferase (TPMT) deficiency--a lucky save and a near miss with azathioprine.
Gardiner SJ; Gearry RB; Barclay ML; Begg EJ
Br J Clin Pharmacol; 2006 Oct; 62(4):473-6. PubMed ID: 16995868
[TBL] [Abstract][Full Text] [Related]
20. Thiopurine S-methyltransferase gene polymorphism in Japanese patients with autoimmune liver diseases.
Tamori A; Shinzaki M; Kosaka S; Hayashi T; Iwai S; Enomoto M; Habu D; Sakaguchi H; Kawada N; Hino M; Shiomi S; Nishiguchi S
Liver Int; 2007 Feb; 27(1):95-100. PubMed ID: 17241387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
